Article

ENTPD1 (CD39) and NT5E (CD73) expression in human Medulloblastoma: an in silico analysis

2023-11-02

Abstract excerpt

Medulloblastoma is the most common malignant tumor in the pediatric population. Its classification has incorporated key molecular variations alongside histological characterization. CD39 (also known as ENTPD1) and CD73 (also known as NT5E), enzymes of the purinergic signaling pathway, act in synergy to generate extracellular adenosine, creating an immunosuppressive tumor microenvironment. Our study examined the ex...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 145da3a1-804b-5cb7-b41f-64dbd3f7aca7
DOI: 10.21203/rs.3.rs-3509100/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

ENTPD1 (CD39) and NT5E (CD73) expression in human Medulloblastoma: an in silico analysisDOI 10.21203/rs.3.rs-3509100/v1Read

ENTPD1 (CD39) and NT5E (CD73) expression in human Glioblastoma: an in silico analysisSemantic proximity Read

Roles and interactions of tumor microenvironment components in medulloblastoma with implications for novel therapeuticsSemantic proximity Read

[Medulloblastoma].Semantic proximity Read

Molecular Diagnostics in Embryonal Brain TumorsSemantic proximity Read

Adult Medulloblastoma: Clinico-molecular Spectrum, An Institutional ExperienceSemantic proximity Read

Affordable panel of techniques for prediction of molecular classification of a series of medulloblastomas in a reference pediatric hospital in ColombiaSemantic proximity Read

Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological FeaturesSemantic proximity Read

The evolution of medulloblastoma therapy to personalized medicineSemantic proximity Read

In silico analysis of long non-coding RNAs in medulloblastoma and its subgroupsSemantic proximity Read

Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future TherapeuticsSemantic proximity Read

Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.Semantic proximity Read

Reproducibility of the NanoString 22‐gene molecular subgroup assay for improved prognostic prediction of medulloblastomaSemantic proximity Read